NIU, F.-W.; ZHANG, Y.-J.; LI, K.; ZHANG, M.-S. Nobiletin acts as a potential anticancer agent against osteosarcoma by regulating ERK and AKT signaling pathways. Bangladesh Journal of Pharmacology, [S. l.], v. 9, n. 3, p. 406–412, 2014. DOI: 10.3329/bjp.v9i3.19567. Disponível em: https://www.banglajol.info/index.php/BJP/article/view/19567. Acesso em: 26 apr. 2024.